C

Celon Pharma SA
WSE:CLN

Watchlist Manager
Celon Pharma SA
WSE:CLN
Watchlist
Price: 25.05 PLN 0.2% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Celon Pharma SA?
Write Note

Wall Street
Price Targets

CLN Price Targets Summary
Celon Pharma SA

Wall Street analysts forecast CLN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLN is 22.54 PLN with a low forecast of 12.12 PLN and a high forecast of 40.95 PLN.

Lowest
Price Target
12.12 PLN
52% Downside
Average
Price Target
22.54 PLN
10% Downside
Highest
Price Target
40.95 PLN
63% Upside
Celon Pharma SA Competitors:
Price Targets
300363
Porton Pharma Solutions Ltd
22% Upside
002821
Asymchem Laboratories Tianjin Co Ltd
26% Upside
SECARE
Swedencare AB (publ)
26% Upside
4506
Sumitomo Pharma Co Ltd
1% Downside
SDZ
Sandoz Group AG
13% Upside
XERS
Xeris Biopharma Holdings Inc
42% Upside
HITI
High Tide Inc
40% Upside

Revenue
Forecast

Revenue Estimate
Celon Pharma SA

For the last 7 years the compound annual growth rate for Celon Pharma SA's revenue is 8%. The projected CAGR for the next 4 years is 9%.

8%
Past Growth
9%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Celon Pharma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat

Net Income
Forecast

Net Income Estimate
Celon Pharma SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLN's stock price target?
Price Target
22.54 PLN

According to Wall Street analysts, the average 1-year price target for CLN is 22.54 PLN with a low forecast of 12.12 PLN and a high forecast of 40.95 PLN.

What is Celon Pharma SA's Revenue forecast?
Projected CAGR
9%

For the last 7 years the compound annual growth rate for Celon Pharma SA's revenue is 8%. The projected CAGR for the next 4 years is 9%.

Back to Top